Research Progress of the Antidepressants Targeting the Monomine Receptors and Glutamate System
Year: 2016
Type: article
Abstract: Depression is a kind of psychiatric disorders and is characterized by persistent low mood, cognitive impairment and behavioral change.Monoamine neurotransmitter reuptake inhibitors are the most common used antidepressants in clinic, but it needs weeks to work and depressed patients may show resistance to the treatment.With the research on the pathogenesis of depression progressing, species of antidepressants have emerged.Agents regulating monoamine (serotonin, dopamine, noradrenaline, etc.) receptors and glutamate receptors including NMDA receptor, AMPA receptor and metabotropic glutamate receptor and agents that inhibit glutamate release gradually become antidepressant research hotspots with the advantage of rapid-onset.Here, antidepressants targeting monoamine receptors and glutamate system in the market and on clinical trial are reviewed, thus providing guidance for the developing trends of new type antidepressants.
Source: Pharmacy Information
Author: 莹莹 任
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2402545401
